Back to overview

Structural Studies of Aggregates and Membrane Proteins

English title Structural Studies of Aggregates and Membrane Proteins
Applicant Riek Roland
Number 117845
Funding scheme Project funding
Research institution Laboratorium für Physikalische Chemie D-CHAB ETH Zürich
Institution of higher education ETH Zurich - ETHZ
Main discipline Physical Chemistry
Start/End 01.01.2008 - 31.12.2009
Approved amount 425'050.00
Show all

Keywords (13)

Nuclear Magnetic Resonance Spectroscopy; protein structures; prions; aggregates; neurodegenerative diseases; membrane protein; protein; 3D strtucture; amyloid fibrils; Alzheimer's disease; Parkinson's disease; membrane proteins; potassium channels

Lay Summary (English)

Lay summary
A number of devastating diseases such as Alzheimer’s, Parkinson’s and prion diseases occur when proteins or fragments of proteins undergo structural changes into insoluble aggregates termed amyloid fibrils. These protein deposition diseases are collectively called amyloid diseases. Each of the amyloid diseases is associated with a disease-specific protein. Its conformational change from soluble form into amyloid fibrils is thought to be the direct cause of the disease in questions and the amyloid fibrils of this protein are a pathological hallmark of the diseases. For example, Alzheimer’s disease is associated with the progressive accumulation of amyloid deposits in the brain called plaques that can be identified under the microscope.
It is our long-term aim to determine the structure of the normal, intermediate and aggregated forms of a variety of amyloid proteins to define motifs associated with amyloid formation, toxicity or/and infectivity. The final goal is a detailed time-resolved description of the conformational switch of amyloid proteins and knowledge about their specific disease-associated properties.

Integral membrane proteins, constituting nearly 1/3 of eukaryotic genes, play central roles in cellular transport processes, intercellular signaling, and growth regulations. Furthermore, membrane proteins are the major drag targets of pharmaceutricla industries. However, of the ~30000 high-resolution protein structures known, only about 30 unique families of integral membrane proteins are represented - not one human membrane protein structure is known. This disparity is accounted for by two bottlenecks in membrane protein structure analysis: (i) high-yield protein production and (ii) 3D structure determination.
It is our long-term goal to advance structural biology of membrane proteins by solution NMR with special emphasis on structural and dynamic insights into GPCRs and ion channels on an atomic level. We will continue to apply Nuclear Magnetic Resonance (NMR) spectroscopy as a major technique towards this aim. Further technical developments will be undertaken to improve the quality of structures of membrane proteins.
Direct link to Lay Summary Last update: 21.02.2013

Responsible applicant and co-applicants


Associated projects

Number Title Start Funding scheme
126488 Structural Studies of Aggregates and Membrane Proteins 01.01.2010 Project funding
121270 Request for a 900 MHz Cryoprobe with Platform 01.09.2008 R'EQUIP